Understanding What Patients Want
At IHH, we believe in touching lives and making a difference for our patients and their loved ones.
Our commitment to our patients is that they will get better treatment, care and outcomes from our network than anywhere else. To keep our commitment, we uphold the highest standards of quality and safety in care, and deliver it with empathy.
From day-to-day healthcare to advanced specialised care, our people go the extra mile to ensure that our patients are in trusted hands.
Defining care from the perspective of our patients – that’s what our Value Driven Outcomes (VDO) initiative in Malaysia, Singapore, Turkey, Brunei and Hong Kong, is all about. By identifying and predicting the outcomes and costs of care, IHH provides accountability and transparency so patients are confident that they are receiving excellent value-for-money services.
VDO has led to changes in clinical practice and better outcomes. Doctors are aligned to a set of quality and functional outcomes. This allows us to drive potential interventions and improve treatment value to the patient.
For a start, four common high-volume and high-impact procedures have been selected for the initiative – Total Knee Replacement (TKR), colonoscopy, Anterior Cruciate Ligament Surgery (ACL) and Percutaneous Coronary Intervention (PCI).
Providing cost-effective and evidence-based treatment is our approach to upholding excellence in healthcare. We continue to invest in new medical technologies that make healthcare better, easier, faster and more affordable for our patients.
For example, we partner with innovative start-ups to sharpen our in-house precision medicine capabilities, enabling doctors and patients to make better informed decisions on how to manage diseases more efficiently and safely.
Come 2022, IHH will be the first private hospital in Southeast Asia to offer proton therapy treatment at its Mount Elizabeth Novena Hospital, Singapore. Our largest single investment in medical technology by far, proton therapy will revolutionise the way cancer is treated in this region with its unique dose deposition that enables the tumour to be targeted more effectively than other treatments.
Delivering care at the patient’s convenience is an ongoing pursuit that has accelerated in response to the global COVID-19 pandemic.
To provide patients around the world with safe and convenient healthcare services, IHH has rolled out telemedicine in our key markets of Malaysia, Singapore, Turkey, India, China and Hong Kong.
As a complement to our brick-and-mortar business, we have also launched mobile apps in multiple countries to enable our patients to make appointments, retrieve medical records and access other healthcare services and information, at their fingertips.
Advancing Cancer Treatment With Proton Therapy
Mount Elizabeth Novena Hospital opened its highly anticipated Proton Therapy Centre on 10 May offering one of the most advanced forms of precision cancer treatments.
24 May 2023
Parkway Shenton Celebrates 50 Years
Singapore’s oldest and most established primary healthcare provider turned 50 on 1 April.
26 Apr 2023
Personalised Care For Her
Precise and personalised diagnostics and treatment are now available to gynaecological cancer patients at Gleneagles Hospital Hong Kong.
26 Apr 2023
IHH Invests In Digital Mental Health Company
IHH has invested into Intellect, Asia’s leading end-to-end digital mental health company, to extend continuum of care.
24 Mar 2023
#AllisWellMumbai Campaign Bags Bronze for Fortis Mumbai
Kudos Fortis Mumbai Hospitals! Their #AllisWellMumbai Campaign clinched bronze at the recent Economic Times Digiplus Awards 2023 (regional category).
24 Mar 2023
#MOVEMENTMATTERS For Better Bone And Joint Health
IHH Healthcare Malaysia launched a nationwide #MovementMatters campaign to promote better bone and joint health among Malaysians.
24 Mar 2023
A Medical First For Fortis
Kudos to our team at Fortis Hospital & Kidney Institute, Kolkata for successfully performing India’s first laparoscopic Urinary Bladder & Ureter Reconstruction surgery.
20 Jan 2023
25 And Going Strong
Congratulations to the Pantai Premier Pathology team on its Silver Jubilee and two new collaborations to strengthen our lab diagnostics capabilities.
26 Dec 2022
A Boost For Antimicrobial Resistance
Gleneagles Hospital Hong Kong local antimicrobial resistance (AMR) programme promotes the responsible use of antibiotics while enhancing public awareness of AMR.
26 Dec 2022
Gifting A Second Chance At Life
Ever heard of Tyrosinemia? It is a rare metabolic liver disorder that manifests as progressive liver failure.
29 Nov 2022